Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€7.32

€7.32

-9.690%
-0.785
-9.690%
€30.98
 
23.12.25 / Frankfurt WKN: A0NBFF / Symbol: OMER / Name: Omeros / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Omeros Corp. Stock

Heavy losses for Omeros Corp. today as the stock fell by -€0.785 (-9.690%).
With 20 Buy predictions and not the single Sell prediction the community is currently very high on Omeros Corp..
With a target price of 30 € there is potential for a 310.12% increase which would mean more than doubling the current price of 7.32 € for Omeros Corp..
Our community identified positive and negative aspects for Omeros Corp. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Omeros Corp. stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.

Pros and Cons of Omeros Corp. in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 30.492
Change
Ends at 24.12.26

Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Ratings data for OMER provided by MarketBeat
Show more

Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Ratings data for OMER provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -11.17%
Target price 31.043
Change
Ends at 01.12.26

Omeros (NASDAQ:OMER) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $36.00 price target on the stock.
Ratings data for OMER provided by MarketBeat
Show more

News

Why Omeros Stock Skyrocketed Today: https://g.foolcdn.com/editorial/images/848689/person-checking-medicine-on-a-shelf-in-a-pharmacy.jpg
Why Omeros Stock Skyrocketed Today

For the most part, the stock market tends to be sedate in the late holiday season. That sure wasn't the case on Wednesday with Omeros (NASDAQ: OMER), which saw a nearly 76% share price leap after

Breakout Momentum Plays You Need to Know About: https://www.marketbeat.com/logos/articles/med_20251021142106_breakout-momentum-plays-you-need-to-know-about.png
Breakout Momentum Plays You Need to Know About

Momentum investors rely on a combination of astute analysis and timing to maximize gains. While this approach can carry a fair degree of risk, the allure of identifying a fast-growing stock and

A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?: https://g.foolcdn.com/editorial/images/837965/individual-investor-looking-at-stock-charts-getty.jpg
A Deal With Novo Nordisk Sent This Stock 181% Higher Overnight. Is It a Buy Now?

Shares of Omeros (NASDAQ: OMER) finished Oct. 14's trading session at $4.10 per share. When the market opened on Oct. 15, the stock was up by 181% at $11.52 per share.

It was a deal with the Danish